# A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction

> **NCT02220803** · PHASE2 · COMPLETED · sponsor: **Göteborg University** · enrollment: 13 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- Sleep-Disordered Breathing
- Blood Pressure
- Hypertension

## Interventions

- **DRUG:** Acetazolamide
- **DEVICE:** nasal Continuous Positive Airway Pressure (nCPAP)

## Key facts

- **NCT ID:** NCT02220803
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02220803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02220803, "A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02220803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*